Organogenesis Holdings (ORGO) EBIAT (2017 - 2025)
Historic EBIAT for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $21.6 million.
- Organogenesis Holdings' EBIAT rose 7490.07% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 11361.79%. This contributed to the annual value of $861000.0 for FY2024, which is 8258.85% down from last year.
- Latest data reveals that Organogenesis Holdings reported EBIAT of $21.6 million as of Q3 2025, which was up 7490.07% from -$9.4 million recorded in Q2 2025.
- Organogenesis Holdings' EBIAT's 5-year high stood at $51.0 million during Q4 2021, with a 5-year trough of -$18.8 million in Q1 2025.
- For the 5-year period, Organogenesis Holdings' EBIAT averaged around $5.7 million, with its median value being $5.3 million (2023).
- Per our database at Business Quant, Organogenesis Holdings' EBIAT skyrocketed by 145088.03% in 2024 and then plummeted by 79728.57% in 2025.
- Organogenesis Holdings' EBIAT (Quarter) stood at $51.0 million in 2021, then tumbled by 85.32% to $7.5 million in 2022, then tumbled by 107.59% to -$568000.0 in 2023, then surged by 1450.88% to $7.7 million in 2024, then soared by 181.08% to $21.6 million in 2025.
- Its EBIAT stands at $21.6 million for Q3 2025, versus -$9.4 million for Q2 2025 and -$18.8 million for Q1 2025.